Amalgamated Bank’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,087
| Closed | -$862K | – | 2993 |
|
|
2023
Q4 | $862K | Sell |
29,087
-1,989
| -6% | -$39.6K | 0.01% | 1226 |
|
|
2023
Q3 | $493K | Buy |
31,076
+652
| +2% | +$10.8K | ﹤0.01% | 1423 |
|
|
2023
Q2 | $574K | Buy |
30,424
+4,293
| +16% | +$50.7K | ﹤0.01% | 1374 |
|
|
2023
Q1 | $100K | Sell |
26,131
-4,741
| -15% | -$20.2K | ﹤0.01% | 2060 |
|
|
2022
Q4 | $153K | Hold |
30,872
| – | – | ﹤0.01% | 1955 |
|
|
2022
Q3 | $148K | Buy |
30,872
+271
| +0.9% | +$1.43K | ﹤0.01% | 1969 |
|
|
2022
Q2 | $138K | Buy |
30,601
+2,189
| +8% | +$9.51K | ﹤0.01% | 2041 |
|
|
2022
Q1 | $135K | Sell |
28,412
-2,297
| -7% | -$12.7K | ﹤0.01% | 2088 |
|
|
2021
Q4 | $228K | Sell |
30,709
-305
| -1% | -$1.9K | ﹤0.01% | 1935 |
|
|
2021
Q3 | $176K | Sell |
31,014
-1,554
| -5% | -$8.98K | ﹤0.01% | 2017 |
|
|
2021
Q2 | $215K | Buy |
32,568
+12,260
| +60% | +$85.5K | ﹤0.01% | 2010 |
|
|
2021
Q1 | $164K | Sell |
20,308
-479
| -2% | -$3.91K | 0.01% | 1519 |
|
|
2020
Q4 | $134K | Buy |
20,787
+883
| +4% | +$5.15K | 0.01% | 1506 |
|
|
2020
Q3 | $72K | Sell |
19,904
-289
| -1% | -$1.17K | ﹤0.01% | 1434 |
|
|
2020
Q2 | $93K | Sell |
20,193
-4,113
| -17% | -$17.5K | ﹤0.01% | 1405 |
|
|
2020
Q1 | $83K | Buy |
24,306
+349
| +1% | +$1.53K | ﹤0.01% | 1517 |
|
|
2019
Q4 | $122K | Buy |
23,957
+249
| +1% | +$845 | ﹤0.01% | 1711 |
|
|
2019
Q3 | $57K | Sell |
23,708
-217
| -0.9% | -$576 | ﹤0.01% | 1699 |
|
|
2019
Q2 | $52K | Buy |
23,925
+1,537
| +7% | +$3.63K | ﹤0.01% | 1745 |
|
|
2019
Q1 | $61K | Buy |
22,388
+756
| +3% | +$3.27K | ﹤0.01% | 1632 |
|
|
2018
Q4 | $104K | Buy |
+21,632
| New | +$131K | ﹤0.01% | 1519 |
|
|
2018
Q3 | – | Sell |
-19,529
| Closed | -$190K | – | 1647 |
|
|
2018
Q2 | $190K | Buy |
19,529
+6,183
| +46% | +$65.2K | ﹤0.01% | 1586 |
|
|
2018
Q1 | $140K | Sell |
13,346
-200
| -1% | -$1.98K | ﹤0.01% | 1506 |
|
|
2017
Q4 | $87K | Buy |
13,546
+2,834
| +26% | +$17.5K | ﹤0.01% | 1582 |
|
|
2017
Q3 | $82K | Sell |
10,712
-158
| -1% | -$1.05K | ﹤0.01% | 1524 |
|
|
2017
Q2 | $77K | Buy |
10,870
+536
| +5% | +$2.45K | ﹤0.01% | 1527 |
|
|
2017
Q1 | $40K | Buy |
10,334
+2
| +0% | +$6 | ﹤0.01% | 1479 |
|
|
2016
Q4 | $21K | Buy |
+10,332
| New | +$20.7K | ﹤0.01% | 1507 |
|
Other funds holding IMGN
Amalgamated Bank's IMGN Position: Q1 2024 in Review
Amalgamated Bank sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 29,087 shares — an estimated $862K sold.
Amalgamated Bank first reported a position in IMGN in Q4 2016 and held it in 28 quarters. The position peaked at $862K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Amalgamated Bank reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Amalgamated Bank sold 29,087 Immunogen Inc shares in Q1 2024, an estimated $862K.
- Amalgamated Bank first reported a position in Immunogen Inc in Q4 2016 and held it in 28 quarters.
- Amalgamated Bank's Immunogen Inc position peaked at $862K in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Amalgamated Bank's 13F filing for Q1 2024, filed 23 Apr 2024.